Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 GenMark DiagnosticsLuminexCardiovascular SystemsAlphatecMiMedx Group
SymbolNASDAQ:GNMKNASDAQ:LMNXNASDAQ:CSIINASDAQ:ATECNASDAQ:MDXG
Price Information
Current Price$23.99$36.80$38.22$17.23$12.30
52 Week RangeHoldHoldBuyBuyBuy
MarketRank™
Overall Score1.51.51.50.81.7
Analysis Score2.01.02.51.53.5
Community Score3.12.02.62.05.0
Dividend Score0.00.80.00.00.0
Ownership Score1.71.71.70.00.0
Earnings & Valuation Score0.61.90.60.60.0
Analyst Ratings
Consensus RecommendationHoldHoldBuyBuyBuy
Consensus Price Target$22.01$37.00$47.57$15.43$20.00
% Upside from Price Target-8.24% downside0.54% upside24.47% upside-10.46% downside62.60% upside
Trade Information
Market Cap$1.75 billion$1.74 billion$1.54 billion$1.64 billion$1.37 billion
Beta3.020.611.191.531.71
Average Volume2,711,742991,164212,548696,709563,470
Sales & Book Value
Annual Revenue$88.02 million$334.64 million$236.54 million$113.43 million$299.26 million
Price / Sales19.925.206.4914.454.57
CashflowN/A$0.59 per shareN/AN/AN/A
Price / CashN/A62.90N/AN/AN/A
Book Value$0.21 per share$10.32 per share$7.62 per share$0.71 per share$0.31 per share
Price / Book114.243.575.0224.2739.68
Profitability
Net Income$-47,350,000.00$-3,840,000.00$-27,240,000.00$-57,000,000.00$-25,580,000.00
EPS($0.82)($0.21)($0.79)($1.09)N/A
Trailing P/E RatioN/A94.36N/AN/AN/A
Forward P/E RatioN/A40.89N/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-16.95%4.60%-10.12%-51.95%-37.28%
Return on Equity (ROE)-39.36%3.75%-11.43%-266.45%-404.08%
Return on Assets (ROA)-13.02%2.73%-8.36%-40.80%-58.81%
Dividend
Annual PayoutN/A$0.40N/AN/AN/A
Dividend YieldN/A1.09%N/AN/AN/A
Three-Year Dividend GrowthN/A54.17%N/AN/AN/A
Payout RatioN/AN/A N/AN/AN/A
Years of Consecutive Dividend GrowthN/A1 YearsN/AN/AN/A
Debt
Debt-to-Equity Ratio0.75%0.39%0.08%8.17%3.70%
Current Ratio4.33%6.45%6.25%1.80%2.99%
Quick Ratio3.84%5.01%5.61%0.92%2.80%
Ownership Information
Institutional Ownership Percentage96.94%88.09%89.70%31.76%4.03%
Insider Ownership Percentage3.25%9.40%3.00%28.18%19.80%
Miscellaneous
Employees6181,325779296735
Shares Outstanding73.09 million47.30 million40.19 million95.15 million111.26 million
Next Earnings Date5/3/2021 (Estimated)5/3/2021 (Estimated)5/6/2021 (Confirmed)5/10/2021 (Estimated)7/5/2021 (Estimated)
OptionableOptionableOptionableOptionableNot OptionableOptionable
SourceHeadline
MiMedx Group (NASDAQ:MDXG) Reaches New 52-Week High at $12.80MiMedx Group (NASDAQ:MDXG) Reaches New 52-Week High at $12.80
americanbankingnews.com - April 12 at 6:36 PM
Is MiMedx Group, Inc. (NASDAQ:MDXG) Popular Amongst Insiders?Is MiMedx Group, Inc. (NASDAQ:MDXG) Popular Amongst Insiders?
finance.yahoo.com - April 12 at 1:58 PM
MiMedx Group (NASDAQ:MDXG) Shares Gap Down to $12.18MiMedx Group (NASDAQ:MDXG) Shares Gap Down to $12.18
americanbankingnews.com - April 7 at 11:00 AM
MiMedx Group (NASDAQ:MDXG) Trading Up 5.7%MiMedx Group (NASDAQ:MDXG) Trading Up 5.7%
americanbankingnews.com - April 6 at 2:30 PM
MiMedx Group (NASDAQ:MDXG) Sets New 12-Month High at $11.44MiMedx Group (NASDAQ:MDXG) Sets New 12-Month High at $11.44
americanbankingnews.com - April 5 at 1:28 PM
MiMedx Group, Inc. (NASDAQ:MDXG) Sees Large Decline in Short InterestMiMedx Group, Inc. (NASDAQ:MDXG) Sees Large Decline in Short Interest
americanbankingnews.com - April 1 at 5:26 AM
MiMedx Group (NASDAQ:MDXG) Shares Up 8.1%MiMedx Group (NASDAQ:MDXG) Shares Up 8.1%
americanbankingnews.com - March 30 at 2:55 PM
MiMedx Awarded Amniotic Tissue Supplier Agreement with Premier® Inc.’s SURPASS™ Purchasing ProgramMiMedx Awarded Amniotic Tissue Supplier Agreement with Premier® Inc.’s SURPASS™ Purchasing Program
finance.yahoo.com - March 30 at 8:46 AM
MiMedx Group (NASDAQ:MDXG) Shares Gap Down to $9.80MiMedx Group (NASDAQ:MDXG) Shares Gap Down to $9.80
americanbankingnews.com - March 29 at 11:48 AM
MiMedx Group (NASDAQ:MDXG) Trading Down 6%MiMedx Group (NASDAQ:MDXG) Trading Down 6%
americanbankingnews.com - March 25 at 11:37 AM
MiMedx Group (NASDAQ:MDXG) Coverage Initiated by Analysts at HC WainwrightMiMedx Group (NASDAQ:MDXG) Coverage Initiated by Analysts at HC Wainwright
americanbankingnews.com - March 25 at 9:00 AM
Contrasting MiMedx Group (NASDAQ:MDXG) and Haemonetics (NYSE:HAE)Contrasting MiMedx Group (NASDAQ:MDXG) and Haemonetics (NYSE:HAE)
americanbankingnews.com - March 23 at 10:44 PM
MiMedx Group (NASDAQ:MDXG) Stock Price Up 5.1%MiMedx Group (NASDAQ:MDXG) Stock Price Up 5.1%
americanbankingnews.com - March 22 at 11:47 AM
MDXG Stock Price Increased 15.21%: Why It HappenedMDXG Stock Price Increased 15.21%: Why It Happened
pulse2.com - March 22 at 9:20 AM
MiMedx Group, Inc. (MDXG) CEO Tim Wright on Q4 2020 Results - Earnings Call TranscriptMiMedx Group, Inc. (MDXG) CEO Tim Wright on Q4 2020 Results - Earnings Call Transcript
seekingalpha.com - March 11 at 4:47 AM
MiMedx Group EPS misses by $0.12, beats on revenueMiMedx Group EPS misses by $0.12, beats on revenue
seekingalpha.com - March 10 at 3:02 PM
MiMedx Group, Inc. to Host Earnings CallMiMedx Group, Inc. to Host Earnings Call
finance.yahoo.com - March 9 at 8:41 AM
MiMedx: Q4 Earnings Snapshot | Raleigh News & ObserverMiMedx: Q4 Earnings Snapshot | Raleigh News & Observer
newsobserver.com - March 8 at 7:17 PM
MiMedx: Q4 Earnings SnapshotMiMedx: Q4 Earnings Snapshot
finance.yahoo.com - March 8 at 7:17 PM
MiMedx to Participate at Upcoming Investor ConferencesMiMedx to Participate at Upcoming Investor Conferences
finance.yahoo.com - March 3 at 12:24 PM
MiMedx to Host Fourth Quarter and Full Year 2020 Operating and Financial Results Conference Call on March 9MiMedx to Host Fourth Quarter and Full Year 2020 Operating and Financial Results Conference Call on March 9
finance.yahoo.com - March 2 at 9:07 AM
Should MiMedx Group (NASDAQ:MDXG) Be Disappointed With Their 41% Profit?Should MiMedx Group (NASDAQ:MDXG) Be Disappointed With Their 41% Profit?
finance.yahoo.com - February 25 at 11:14 AM
CEO Who Blamed His Cancer on Short Sellers Set for SentencingCEO Who Blamed His Cancer on Short Sellers Set for Sentencing
finance.yahoo.com - February 23 at 12:56 PM
MDXG: From Womb to WoundMDXG: From Womb to Wound
finance.yahoo.com - February 18 at 2:45 PM
Reminder: MiMedx to Present at the 39th Annual J.P. Morgan Healthcare ConferenceReminder: MiMedx to Present at the 39th Annual J.P. Morgan Healthcare Conference
finance.yahoo.com - January 6 at 8:12 AM
DateCompanyBrokerageAction
3/23/2021GenMark DiagnosticsCowenReiterated Rating
3/23/2021GenMark DiagnosticsBTIG ResearchReiterated Rating
3/22/2021GenMark DiagnosticsNeedham & Company LLCReiterated Rating
3/22/2021GenMark DiagnosticsCanaccord GenuityReiterated Rating
3/15/2021GenMark DiagnosticsWilliam BlairDowngrade
2/11/2020GenMark DiagnosticsRaymond JamesDowngrade
12/11/2019GenMark DiagnosticsJPMorgan Chase & Co.Downgrade
4/13/2021LuminexPiper SandlerDowngrade
11/6/2018LuminexCitigroupLower Price Target
8/7/2018LuminexJefferies Financial GroupReiterated Rating
5/7/2018LuminexDeutsche Bank AktiengesellschaftUpgrade
3/17/2021Cardiovascular SystemsOppenheimerReiterated Rating
2/15/2021Cardiovascular SystemsAegisReiterated Rating
12/16/2020Cardiovascular SystemsNorthland SecuritiesBoost Price Target
12/14/2020Cardiovascular SystemsSVB LeerinkBoost Price Target
7/17/2020Cardiovascular SystemsBarclaysInitiated Coverage
5/6/2020Cardiovascular SystemsLake Street CapitalLower Price Target
10/17/2019Cardiovascular SystemsGuggenheimInitiated Coverage
7/16/2019Cardiovascular SystemsStifel NicolausDowngrade
4/11/2019Cardiovascular SystemsBank of AmericaDowngrade
3/11/2021AlphatecHC WainwrightBoost Price Target
10/31/2019AlphatecPiper Jaffray CompaniesBoost Price Target
(Data available from 4/16/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.